Summit Therapeutics PLC Capital Reinvestment Ratio
Summit Therapeutics PLC capital reinvestment ratio. Summit Therapeutics PLC (SMMT) has a Capital Reinvestment Ratio of 0.23x as of December 2022, meaning it reinvests 0% of its operating cash flow ($4.23 Million) in capital expenditures ($994.38K). Check SMMT cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Summit Therapeutics PLC (2004–2016)
Capital reinvestment ratio of Summit Therapeutics PLC from 2004 to 2016. This chart tracks Summit Therapeutics PLC's Capital Reinvestment Ratio across 2 annual periods. Also explore SMMT net asset momentum to track the company's year-over-year net asset growth rate.
Summit Therapeutics PLC Capital Reinvestment Ratio by Year (2004–2016)
Summit Therapeutics PLC capital reinvestment ratio by year from 2004 to 2016. For the full cash flow conversion analysis, see SMMT cash flow conversion.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2016 | 0.01x | $15.18 Million | $110.00K | ▼ -98.4% |
| 2004 | 0.44x | $29.74K | $13.18K | — |